New Study Reveals Elevated Rates of Blood Cancer Precursor Condition in Groups at High Risk for Multiple Myeloma

Dana-Farber Cancer Institute research shows elevated rates of a blood cancer precursor condition in groups at high risk for multiple myeloma. Dr. Irene Ghobrial and Dr. Habib El-Khoury detail the first findings from the PROMISE study presented at ASH 2021.

Read related article >>


January 4, 2022

Created by


Related Presenters

Irene Ghobrial, MD

Irene Ghobrial, MD

Director, Clinical Investigator Research Program

Dr. Ghobrial received her MD in 1995 from Cairo University School of Medicine, Egypt. She completed her Internal Medicine training at Wayne State University, Mich., and her Hematology/Oncology subspecialty training at Mayo Clinic College of Medicine, Minn.

View full profile

Habib El- Khoury, MD

Habib El- Khoury, MD

Doctor of Medicine | Postdoctoral Research Fellow at Dana-Farber Cancer Institute

View full profile